Cargando…
Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography
BACKGROUND: Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been demonstrated to produce significantly greater reduction in LDL cholesterol levels and cardiovascular events than standard statin therapy. However, evidence on the impact of PCSK9 inhibitors on coronary plaque comp...
Autores principales: | Gao, Fei, Wang, Zhi Jian, Ma, Xiao Teng, Shen, Hua, Yang, Li Xia, Zhou, Yu Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436513/ https://www.ncbi.nlm.nih.gov/pubmed/34511134 http://dx.doi.org/10.1186/s12944-021-01528-3 |
Ejemplares similares
-
Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
por: Gao, Fei, et al.
Publicado: (2022) -
Characteristics of coronary artery ectasia and accompanying plaques: an optical coherence tomography study
por: Yu, Huai, et al.
Publicado: (2023) -
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography
por: Galiuto, L., et al.
Publicado: (2021) -
Optical Coherence Tomography: An Eye Into the Coronary Artery
por: Gupta, Ankush, et al.
Publicado: (2022) -
Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease
por: Sun, Renhua, et al.
Publicado: (2021)